Ageing, Work, and Health Research Unit and the Centre for Excellence in Population Ageing Research, Faculty of Health Sciences, University of Sydney, Lidcombe, 2141 New South Wales, Australia.
BMJ. 2012 Aug 7;345:e4547. doi: 10.1136/bmj.e4547.
To determine whether a lifestyle integrated approach to balance and strength training is effective in reducing the rate of falls in older, high risk people living at home.
Three arm, randomised parallel trial; assessments at baseline and after six and 12 months. Randomisation done by computer generated random blocks, stratified by sex and fall history and concealed by an independent secure website.
Residents in metropolitan Sydney, Australia.
Participants aged 70 years or older who had two or more falls or one injurious fall in past 12 months, recruited from Veteran's Affairs databases and general practice databases. Exclusion criteria were moderate to severe cognitive problems, inability to ambulate independently, neurological conditions that severely influenced gait and mobility, resident in a nursing home or hostel, or any unstable or terminal illness that would affect ability to do exercises.
Three home based interventions: Lifestyle integrated Functional Exercise (LiFE) approach (n=107; taught principles of balance and strength training and integrated selected activities into everyday routines), structured programme (n=105; exercises for balance and lower limb strength, done three times a week), sham control programme (n=105; gentle exercise). LiFE and structured groups received five sessions with two booster visits and two phone calls; controls received three home visits and six phone calls. Assessments made at baseline and after six and 12 months.
Primary measure: rate of falls over 12 months, collected by self report. Secondary measures: static and dynamic balance; ankle, knee and hip strength; balance self efficacy; daily living activities; participation; habitual physical activity; quality of life; energy expenditure; body mass index; and fat free mass.
After 12 months' follow-up, we recorded 172, 193, and 224 falls in the LiFE, structured exercise, and control groups, respectively. The overall incidence of falls in the LiFE programme was 1.66 per person years, compared with 1.90 in the structured programme and 2.28 in the control group. We saw a significant reduction of 31% in the rate of falls for the LiFE programme compared with controls (incidence rate ratio 0.69 (95% confidence interval 0.48 to 0.99)); the corresponding difference between the structured group and controls was non-significant (0.81 (0.56 to 1.17)). Static balance on an eight level hierarchy scale, ankle strength, function, and participation were significantly better in the LiFE group than in controls. LiFE and structured groups had a significant and moderate improvement in dynamic balance, compared with controls.
The LiFE programme provides an alternative to traditional exercise to consider for fall prevention. Functional based exercise should be a focus for interventions to protect older, high risk people from falling and to improve and maintain functional capacity.
Australia and New Zealand Clinical Trials Registry 12606000025538.
确定将平衡和力量训练的生活方式综合方法用于降低居家的高风险老年人的跌倒率是否有效。
三臂、随机平行试验;基线和 6 个月及 12 个月时评估。通过计算机生成的随机块进行随机分组,按性别和跌倒史分层,并通过独立的安全网站进行隐藏。
澳大利亚悉尼大都市。
年龄在 70 岁或以上、过去 12 个月中有两次或两次以上跌倒或一次受伤跌倒的参与者,从退伍军人事务数据库和一般实践数据库中招募。排除标准为中度至重度认知问题、无法独立行走、严重影响步态和活动能力的神经疾病、居住在养老院或招待所、或任何不稳定或终末期疾病,这将影响锻炼能力。
三种基于家庭的干预措施:生活方式综合功能锻炼(LiFE)方法(n=107;教授平衡和力量训练原则,并将选定的活动整合到日常生活中)、结构化方案(n=105;平衡和下肢力量锻炼,每周进行三次)、假对照方案(n=105;温和运动)。LiFE 和结构化组接受 5 次会议,2 次强化访问和 2 次电话访问;对照组接受 3 次家访和 6 次电话访问。在基线和 6 个月及 12 个月时进行评估。
主要指标:12 个月内的跌倒率,通过自我报告收集。次要指标:静态和动态平衡;脚踝、膝盖和臀部力量;平衡自我效能;日常生活活动;参与度;习惯性体力活动;生活质量;能量消耗;体重指数;和去脂体重。
经过 12 个月的随访,LiFE、结构化运动和对照组分别记录了 172、193 和 224 次跌倒。LiFE 方案的总体跌倒发生率为 1.66 人年,而结构化方案为 1.90,对照组为 2.28。我们发现 LiFE 方案的跌倒率显著降低了 31%,与对照组相比(发生率比 0.69(95%置信区间 0.48 至 0.99));结构化组与对照组的差异无统计学意义(0.81(0.56 至 1.17))。LiFE 组的静态平衡在八级层次量表、脚踝力量、功能和参与度方面明显优于对照组。LiFE 和结构化组与对照组相比,动态平衡有显著和中度改善。
LiFE 方案为跌倒预防提供了一种替代传统运动的方法。基于功能的锻炼应该成为干预措施的重点,以保护高风险的老年人免受跌倒,并改善和维持他们的功能能力。
澳大利亚和新西兰临床试验注册中心 12606000025538。